Last reviewed · How we verify

NCT03605485

The Evaluation of a Novel Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea

Completed NA Last updated 15 August 2018
What this trial tests

NA trial testing Nasal Pillows CPAP mask in Obstructive Sleep Apnea in 9 participants. Completed in 10 August 2018.

Timeline
7 August 2018
Primary endpoint
10 August 2018
10 August 2018

Quick facts

Lead sponsorFisher and Paykel Healthcare
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment9
Start date7 August 2018
Primary completion10 August 2018
Estimated completion10 August 2018
Sites1 location across New Zealand

Drugs / interventions tested

Conditions studied

Sponsor

Fisher and Paykel Healthcare — full company profile →

Who can join

18 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This investigation is a prospective, non randomized, non blinded study. This investigation is designed to evaluate the performance, comfort and ease of use with the F\&P trial nasal pillows mask amongst Obstructive Sleep Apnea (OSA) participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other Fisher and Paykel Healthcare trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03605485.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing